Salarius Pharmaceuticals, Inc. financial data

Symbol
SLRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2450 Holcombe Blvd, Suite J 608, Houston, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
Flex Pharma, Inc. (to 7/22/2019)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 32.6 % -32.5%
Return On Equity -140 % +40.8%
Return On Assets -106 % +33.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.44M shares -63.4%
Common Stock, Shares, Outstanding 1.44M shares -63.4%
Common Stock, Value, Issued 144 USD -63.5%
Weighted Average Number of Shares Outstanding, Basic 1.28M shares +173%
Weighted Average Number of Shares Outstanding, Diluted 1.28M shares +173%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 655K USD -94.5%
General and Administrative Expense 4.56M USD -30.9%
Operating Income (Loss) -5.22M USD +71.7%
Net Income (Loss) Attributable to Parent -4.99M USD +72.3%
Earnings Per Share, Basic 11.5 USD/shares +85.4%
Earnings Per Share, Diluted 11.5 USD/shares +85.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.28M USD -56.7%
Other Assets, Current 119K USD +43.2%
Assets, Current 3.82M USD -54.1%
Other Assets, Noncurrent 36.5K USD -54.6%
Assets 3.86M USD -54.1%
Accounts Payable, Current 166K USD -84.8%
Liabilities 935K USD -59.7%
Retained Earnings (Accumulated Deficit) -80.5M USD -6.62%
Stockholders' Equity Attributable to Parent 2.92M USD -51.9%
Liabilities and Equity 3.86M USD -54.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.35M USD +57.3%
Net Cash Provided by (Used in) Financing Activities -173K USD -151%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 1.44M shares -63.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.53M USD +46.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.28M USD -56.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.02K USD
Deferred Tax Assets, Valuation Allowance 15.9M USD +21.9%
Deferred Tax Assets, Gross 15.9M USD +21.9%
Deferred Tax Assets, Operating Loss Carryforwards 6.16M USD +57.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 83.4M USD +2.25%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.11K USD -33.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%